Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Cancer research

Global Disparities in Gender Representation in Cancer Research Publications

A recent study published in BMJ Oncology reveals a persistent sex imbalance in cancer research publications, with variations among different regions and countries. Despite a slight increase in female authors, countries in the Far East, Middle East, Western Europe, and North America show poor performance. In contrast, Eastern and Southern European countries and those in Latin America excel in female authorship. The study highlights challenges faced by women in academia and emphasizes the need for evidence-based policies to promote gender diversity in cancer research.

Global Team Led by Dr. Yael Mossé Awarded Multimillion-Dollar Grant for Childhood Cancer Research

Dr. Yael Mossé and her global team have been awarded a multimillion-dollar grant to develop groundbreaking research in childhood cancer. The team aims to develop transformative new therapies for previously undruggable forms of childhood cancer, offering hope for improved treatment outcomes and quality of life for young patients.

Washington University School of Medicine Joins National Clinical Trials Network for Cancer Screening

Washington University School of Medicine in St. Louis has joined a new national clinical trials network launched by the National Cancer Institute (NCI) to investigate emerging technologies for cancer screening. The goal of the network is to reduce cancer-related illnesses and deaths, with a key priority being the inclusion of participants from diverse populations. Collaborating with Siteman Cancer Center, the investigators will lead trials in Missouri and parts of Illinois, aiming to reach diverse populations, including those living in underserved areas. The network’s primary focus is to evaluate the effectiveness of a screening technology designed to detect multiple cancers with a single blood test, with the researchers aiming to determine whether such tests can detect cancer early and ultimately save lives.

Tokyo Researchers Make Groundbreaking Discovery in DNA Repair

Researchers from Tokyo Metropolitan University have made a groundbreaking discovery in the field of DNA repair, shedding light on the role of the RecA protein in homologous recombination. This process is crucial for repairing breaks in double-stranded DNA, and the…

Cambridge Researchers Initiate Groundbreaking Clinical Trial for Capsule Sponge in Oesophageal Cancer Prevention

Oesophageal cancer is a significant health concern, and researchers at Cambridge have initiated a groundbreaking clinical trial to investigate the effectiveness of a ‘capsule sponge’ in preventing this type of cancer. The trial, named BEST4, is set to commence at…